Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19. Association between asthma and autoimmune disorder myasthenia gravis: meta-analysisFindings come from a meta-analysis of studies by researchers in Thailand involving both asthma and the less common autoimmune disorder MG with results published in Lung Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health–Americas. Six things to tell patients about the Delta variant of SARS-CoV-2 Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States One jab has almost no effect against Delta: study According to a recently published study, two shots are better than one when it comes to protection against the SARS-CoV-2 Delta, as well as other, variants of the virus. 2021 Canadian guidelines now available for management of asthma Canadian Thoracic Society issues updated guidelines for the diagnosis and management of asthma in preschoolers, children and adults. COVID-19 outbreak grows in N.W.T., military and Red Cross nurses deployed Ontario's Vaccine Clinical Advisory Group recommends some cohorts receive third mRNA vaccine The update outlines the specific populations who would most benefit from a third or booster shot. QUIZ: What do you know about COPD exacerbations? Take our weekly clinical quiz. Outside of giving birth, the most common cause of hospitalization in Canada is COPD exacerbations. Health Canada considering new oral antiviral for treatment of COVID-19 Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19. First Previous 24 25 26 27 28 Next Last
